INS and diabetes mellitus: Diabetes mellitus developed after a median of 2.4 months and was more frequent with anti-PD1/PDL1. 62% of patients had an acute onset with ketoacidosis with a mortality of 5%, and some became chronic. All patients were treated with insulin therapy and in 12% with immunosuppressive therapy.